Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August-September 2014.
Laboratory Corp. of America Holdings acquired publicly traded LipoScience Inc. (diagnostics for cardiovascular and metabolic conditions) for $5.25 per share in cash (a 65% premium), or $80mm. (Sep.)
LipoScience will become a wholly owned LabCorp subsidiary. LipoScience develops personalized tests based on nuclear magnetic resonance (NMR) technology. Its...